Cancer stem cell marker CD44 in epithelial ovarian tumors: Association with adverse prognostic features in invasive carcinomas
Indian Journal of Pathology and Microbiology · 2026-07 · 69 (3) · 436-441
DOI: 10.4103/ijpm.ijpm_250_26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Pathology and Microbiology, online erschienen am 30.10.2026. Verfasst von Shikhar Chohan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India. Hauptthemen laut MEDLINE: Hyaluronan Receptors, Biomarkers, Tumor, Carcinoma, Ovarian Epithelial, Ovarian Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
CD44 is a cancer stem cell marker implicated in tumor progression, metastasis, and chemoresistance in various malignancies, including ovarian cancer. Its expression in epithelial ovarian tumors and its association with prognostic parameters remain areas of active investigation.
Objectives
To evaluate CD44 expression in epithelial ovarian tumors and determine its correlation with clinicopathological parameters in invasive ovarian carcinomas. Materials and Methods: This cross-sectional study included 78 cases of histologically confirmed epithelial ovarian tumors over an 18-month period at a tertiary care center. Immunohistochemistry for CD44 was performed, and expression was categorized into low expression (scores 0–1) and high expression (scores 2–3). CD44 expression was analyzed across tumor categories and evaluated for its association with age, lymphovascular invasion, tumor budding, and FIGO stage; histological grade was assessed among invasive carcinomas.
Results
CD44 expression was analyzed across tumor categories and evaluated for its association with age, histological grade, lymphovascular invasion, tumor budding, and FIGO stage. High CD44 expression showed significant associations with older age, higher tumor grade, lymphovascular invasion, increased tumor budding, and advanced FIGO stage ( P < 0.05).
Conclusions
CD44 expression is significantly associated with adverse histopathological features in invasive epithelial ovarian carcinomas, supporting its potential role as a prognostic biomarker and therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India.
Zitieren
APA
Chohan, S., Khambra, P., Sharma, S., & Punhani, P. (2026). Cancer stem cell marker CD44 in epithelial ovarian tumors: Association with adverse prognostic features in invasive carcinomas. Indian Journal of Pathology and Microbiology, 69(3), 436-441. https://doi.org/10.4103/ijpm.ijpm_250_26
Vancouver
Chohan S, Khambra P, Sharma S, Punhani P. Cancer stem cell marker CD44 in epithelial ovarian tumors: Association with adverse prognostic features in invasive carcinomas. Indian Journal of Pathology and Microbiology. 2026;69(3):436-441. doi:10.4103/ijpm.ijpm_250_26
BibTeX
@article{Chohan2026,
author = {Chohan, Shikhar and Khambra, Poonam and Sharma, Sonam and Punhani, Pallavi},
title = {Cancer stem cell marker CD44 in epithelial ovarian tumors: Association with adverse prognostic features in invasive carcinomas},
journal = {Indian Journal of Pathology and Microbiology},
year = {2026},
volume = {69},
number = {3},
pages = {436--441},
doi = {10.4103/ijpm.ijpm_250_26}
}
EUVIMED